ClinicalTrials.gg
Not yet recruitingNCT07921056Updated Nov 6, 2026

Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.

An interventional study of Hip Hinge Movement Training and Gluteus Activation Exercises in Low Back Pain, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

the effects of hip hinge exercises in non-specific low back pain patients along with that we will measure the range of motion of lumbar region. Low back pain (LBP) is a prevalent musculoskeletal condition worldwide and a leading cause of disability, affecting individuals' physical functioning and quality of life.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • hip hinge exercises
  • NPRS
  • ODI
  • conventional rehabilitation
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 52 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18-60 years
  • Both genders
  • Diagnosed with chronic non-specific low back pain
  • Pain intensity > 4 on NPRS on baseline

Exclusion criteria

Exclusion Criteria:

  • Specific causes of back pain (radiculopathy, spondylolisthesis, spinal stenosis, fracture, infection, )
  • History of spinal surgery in past 12 months.
  • Neurological deficits affecting safe exercise performance.
  • Pregnancy or unstable medical conditions.
  • Participation in other structured rehabilitation programs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Group A

    For Group A 3 session per week within pain-free limits, progressing as tolerated and 45-60 minutes time per session.

    Other: Hip Hinge Movement Training · Other: Gluteus Activation Exercises · Other: Hip Mobility Drills

  • Other
    Group B

    For Group B 3 sessions per week within pain free range of motion as tolerated and session last for 45- 60 minutes per session

    Other: Conventional Rehabilitation Components

Interventions

  • OtherHip Hinge Movement Training

    Functional drills focusing on hip flexion with neutral spine including body weight hip hinging with dowel feedback and progression as tolerated. Exercises will emphasize gluteus activation and eccentric protocol to minimize lumbar flexion.

  • OtherGluteus Activation Exercises

    Spine bridges and clamshells to strengthen the Gluteus Maximus and Medius, addressing posterior chain weakness commonly seen in NSLBP.

  • OtherHip Mobility Drills

    Active and static stretching for hip flexors and extensors in pain free range of motion.

  • OtherConventional Rehabilitation Components

    Core stabilization exercises such as abdominal bracing, pelvic tilts, quadruped arm/leg extensions, trunk strengthening prone back extensions and lumbar stretching.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating scale (NPRS) for pain

    The intensity of NSLBP will be measured on the Numeric pain rationg scale which will be assessed verbally by a blinded assessor. This scale is routinely utilized for NSLBP, and is valid, responsive and is easy to administer in a clinical setting. The NPRS is scored on an 11 point scale (0-10) where 0 represents no pain and 10 represents the worst imaginable pain. Excellent interrater reliability, excellent internal consistency for NPRS in participants aged 25-55 (Cronbach's alpha =0.88)

    Time frame: 6 weeks

  2. Oswestry disability index (ODI)

    The Oswestry Disability Index (ODI) is a validated self-report questionnaire used to measure functional disability related to low back pain. It includes items on pain intensity, personal care, lifting, walking, sitting, standing, sleeping, social life and travel. Scores range from 0-100% where higher scores indicate greater disability. ODI is recognized as a gold standard outcome in NSLBP clinical trails and exhibits excellent reliability and responsiveness in adults with chronic low back pain.

    Time frame: 6 weeks

  3. Goniometer for Lumbar Range of Motion (ROM)

    Lumbar ROM will be assessed using a manual goniometer according to standard clinical protocols. Common movements measured include lumbar flexion (forward bending), extension (backward bending), lateral flexion (side bending) and rotation. Lumbar ROM assessment has demonstrated acceptable reliability for clinical use and movement deficits have been associated with NSLBP in biomechanical studies.

    Time frame: 6 weeks

07

Study locations

1 site
  • Al Shafi Hospital Lahore
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jan 2027, 3 months later.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 3 months is below that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Jan 2027
CompletionEst.
Feb 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921056
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Imran IMRAN Amjad, PHD
Contact
imran.amjad@riphah.edu.pk
9233224390125
Mehar Un Nisa Mehar Un Nisa
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion